Ampio Pharmaceuticals, Inc.(NYSE Amex Equities : AMPE)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corporation Plc Sponsored ADR | -6.66% | 17.51 | 2.0% | $159.03m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -4.60% | 109.85 | 18.6% | $127.35m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.42% | 136.60 | 2.3% | $113.61m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -4.07% | 168.83 | 6.3% | $91.29m | |
| SAGE | SAGE Therapeutics, Inc. | -0.80% | 156.72 | 8.8% | $89.75m | |
| HZNP | Horizon Pharma plc | -3.83% | 26.84 | 7.3% | $83.66m | |
| PRGO | Perrigo Co. Plc | -2.76% | 47.24 | 6.8% | $66.07m | |
| ICLR | ICON Plc | -2.83% | 132.88 | 4.1% | $57.01m | |
| UTHR | United Therapeutics Corporation | -1.78% | 120.80 | 14.3% | $54.81m | |
| MNK | Mallinckrodt Plc | -7.23% | 22.08 | 21.0% | $51.42m | |
| PTLA | Portola Pharmaceuticals, Inc. | -4.94% | 31.97 | 7.6% | $42.48m | |
| AERI | Aerie Pharmaceuticals, Inc. | -4.93% | 46.82 | 6.9% | $40.04m | |
| ENDP | Endo International Plc | -4.91% | 8.33 | 8.9% | $36.51m | |
| MYOK | MyoKardia, Inc. | -2.71% | 54.31 | 2.4% | $35.96m | |
| MDCO | Medicines Company | -5.14% | 26.58 | 21.8% | $29.62m |
Company Profile
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.